Clinical ResearchAbsorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison: The BVS-EXAMINATION Study (Bioresorbable Vascular Scaffold-A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction)
Under an Elsevier user license
open archive
Key Words
ABSORB
everolimus-eluting stent
STEMI
Abbreviations and Acronyms
BVS
bioresorbable vascular scaffold(s)
CI
confidence interval
DOCE
device-oriented endpoint
EES
everolimus-eluting stent(s)
GP
glycoprotein
HR
hazard ratio
MI
myocardial infarction
PCI
percutaneous coronary intervention
RR
relative risk
STEMI
ST-segment elevation myocardial infarction
TIMI
Thrombolysis in Myocardial Infarction
Cited by (0)
This work was funded in part by the “Ministerio de Economia y Competitividad, Instituto de Salud Carlos III” (RIC RD12/0042/0006). Dr. Brugaletta has received speakers fees from Abbott and AstraZeneca. Dr. Gori has received speakers honoraria from Abbott Vascular. Dr. Kocka has received speaker honorarium from Abbott Vascular; has been a transcatheter aortic valve implantation proctor for and received an institutional grant from Medtronic; and has received grant support from Zentiva. Dr. Widimsky has received speakers honoraria from Abbott. Dr. Sabaté has served as a consultant for Abbott and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.